verified SJR 0,517 · Q2 • database Scopus / SJR & Web of Science indexed

Germany · Springer Verlag

workspace_premium Q2 — Radiology, Nuclear Medicine and Imaging lock_open Open Access

Nuclear Medicine and Molecular Imaging

Nuclear Medicine and Molecular Imaging is a journal indexed in SJR in Radiology, Nuclear Medicine and Imaging with an H index of 35. It has a price of 2690 €. It has an SJR impact factor of 0,517 and it has a best quartile of Q2. It is published in English. It has an SJR impact factor of 0,517.

ISSN: 1869-3474

Publisher: Springer Verlag

Category: Radiology, Nuclear Medicine and Imaging

Indexation: verifiedScopus / SJR verifiedWeb of Science

open_in_new Portal NPD menu_book Guidelines NPD

schedule CountryOfPapers database fields

SJR Impact Factor trending_up

0,517 Q2

H-index 35

Acceptance rate pie_chart

37%

Source Acceptance_Rate

Time to publication hourglass_top

NPD

Field NPD

Publication cost (APC) payments

2.690 € Open Access

Non-OA path 0 €

Metrics

Scimago and CountryOfPapers database fields

Scopus / SJR Web of Science

SJR Impact

0,517

H-index

Docs (year)

Docs 3y

142

Total refs

1978

Cites 3y

240

Citable 3y

128

Cites/Doc 2y

Ref/Doc

29.52

Immediate OA

2690 €

Embargoed OA

NPD

Non OA / Submission

0 €

shield Researcher voice

Name good journals. Call out predatory ones.

Share what peer review, fees, and timelines were really like. Praise fair editors. Flag APC traps, fake metrics, or spam solicitations — with facts from your submission.

Fair & fast peer review Clear APC / no surprise fees Suspected predatory Fake impact claims

rate_review Write an honest review

Researcher reviews

sentiment_dissatisfied No reviews yet — be the first to share an honest experience.

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID * * Only to validate authenticity — identity is not shown publicly.

Best articles by citations

Bilateral Tubo-Ovarian Abscess Mimics Ovarian Cancer on MRI and 18F-FDG PET/CT

Whole-Body Bone Scan Findings after High-Intensity Focused Ultrasound (HIFU) Treatment

Contribution of Radionuclide Theranostics for Managing Intractable Malignancies

Comparison of Therapeutic Efficacy and Clinical Parameters Between Recombinant Human Thyroid Stimulating Hormone and Thyroid Hormone Withdrawal in High-Dose Radioiodine Treatment with Differentiated Thyroid Cancer

Comparison of the Intraperitoneal, Retroorbital and per Oral Routes for F-18 FDG Administration as Effective Alternatives to Intravenous Administration in Mouse Tumor Models Using Small Animal PET/CT Studies

Comparison of Diagnostic Sensitivity and Quantitative Indices Between 68Ga-DOTATOC PET/CT and 111In-Pentetreotide SPECT/CT in Neuroendocrine Tumors: a Preliminary Report

Comparison between 18F-FDG PET/CT and EMG Mapping for Identifying Dystonic Superficial Muscles in Primary Cervical Dystonia: Preliminary Results

Comparative Analysis of 99mTc-MDP Three-Phase Bone Scan with SPECT/CT and 99mTc-HMPAO-Labeled WBC SPECT/CT in the Differential Diagnosis of Clinically Suspicious Post-traumatic Osteomyelitis

Clinical Usefulness of F-18 FDG PET/CT in Papillary Thyroid Cancer with Negative Radioiodine Scan and Elevated Thyroglobulin Level or Positive Anti-thyroglobulin Antibody

Clinical Personal Connectomics Using Hybrid PET/MRI

Cerebral Toxoplasmosis in a Patient with AIDS on F-18 FDG PET/CT

Brain Metastasis from Neuroblastoma Depicted by 18F-DOPA PET/CT

SHOW MORE ARTICLES

Bone and Calcified Soft Tissue Metastases of Medullary Thyroid Carcinoma Better Characterized on 18F-Fluoride PET/CT than on 68Ga-Dotatate PET/CT

18F-FDG PET Demonstration of Cancer Recurrence Presenting as Dermatomyositis in a Rare Case of Primary Pleural Lymphoma

Autoclustering of Non-small Cell Lung Carcinoma Subtypes on 18F-FDG PET Using Texture Analysis: A Preliminary Result

Assessment of Therapy Response by 18F-FDG PET/CT for a Patient with Cutaneous and Subcutaneous Mycobacterium Infection and Coexisting Lymphoma

Assessment of Therapeutic Effect of Sunitinib by 11C-Acetate PET Compared with FDG PET Imaging in a Patient with Metastatic Renal Cell Carcinoma

Analysis of Clinical Factors for the Determination of Optimal Serum Level of Thyrotropin After Recombinant Human Thyroid-Stimulating Hormone Administration

An Unusual Case of Extramedullary Plasmacytoma of the Hypopharynx Detected by 18F-FDG PET/CT

Adrenocortical Carcinoma: False Positive in an I-123 Metaiodobenzylguanedine Scan

Absent Sternum as the First Manifestation of Bone Metastasis on Bone Scintigraphy

A Rare Case of Malignant Granular Cell Tumor of the Colon Incidentally Detected by 18F-FDG Positron Emission Tomography/Computed Tomography

3'-Deoxy-3'-[18F]fluorothymidine and O-(2-[18F]fluoroethyl)-L-tyrosine PET in Patients with Suspicious Recurrence of Glioma after Multimodal Treatment: Initial Results of a Retrospective Comparative Study

18F-FDG PET/MR Refines Evaluation in Newly Diagnosed Metastatic Urethral Adenocarcinoma

FAQs

Nuclear Medicine and Molecular Imaging has an SJR of 0,517 (best quartile Q2) in the CountryOfPapers database.

Immediate OA APC is 2690 EUR. Non-OA / submission fee is 0 EUR.

The acceptance rate recorded for Nuclear Medicine and Molecular Imaging is 37%.

Nuclear Medicine and Molecular Imaging

Metrics

Name good journals. Call out predatory ones.

Researcher reviews

Best articles by citations

FAQs

What is the SJR of Nuclear Medicine and Molecular Imaging?

What is the APC / publication cost?

What is the acceptance rate?